Dr. Rory Remmel’s Wins the James R. Gillette Drug Metabolism and Disposition Best Paper of 2017

Jan. 10, 2018

Dr. Rory Remmel has won the James R. Gillette Drug Metabolism and Disposition Best Paper of 2017 in the Metabolism category for his coauthored paper “CRISPR/Cas9 Genetic Modification of CYP3A5 *3 in HuH-7 Human Hepatocyte Cell Line Leads to Cell Lines with Increased Midazolam and Tacrolimus Metabolism.” You can read about the award here